Chris Storgard

Affiliations

  • Chief Medical Officer at Design Therapeutics Inc. (DSGN), 2025-05-23
  • Chief Medical Officer at Fate Therapeutics Inc (FATE), 2018-01-17
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FATE $2.66 37,593 $99,997.38 37,593 2016-11-23 Filing